• 1. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

Methyl Piperidine-3-carboxylate Hydrochloride (CAS No. 89895-55-6): A Comprehensive Overview

Methyl Piperidine-3-carboxylate Hydrochloride, identified by its CAS number 89895-55-6, is a significant compound in the field of pharmaceutical chemistry. This compound has garnered considerable attention due to its versatile applications in drug development and medicinal research. The Methyl Piperidine-3-carboxylate Hydrochloride structure, characterized by a piperidine ring substituted with a carboxylate group and a methyl ester, makes it a valuable intermediate in synthesizing various bioactive molecules.

The piperidine moiety is a prominent pharmacophore in many pharmaceutical agents, contributing to their binding affinity and metabolic stability. The presence of the carboxylate and methyl ester functionalities enhances the compound's reactivity, making it a crucial building block for further chemical modifications. In recent years, the demand for such intermediates has surged, driven by advancements in drug discovery technologies and the need for more sophisticated molecular architectures.

Recent studies have highlighted the potential of Methyl Piperidine-3-carboxylate Hydrochloride in developing novel therapeutic agents. For instance, researchers have explored its utility in creating kinase inhibitors, which are pivotal in treating cancers and inflammatory diseases. The unique structural features of this compound allow for precise tuning of pharmacokinetic properties, including solubility and bioavailability. This has opened new avenues for designing drugs with improved efficacy and reduced side effects.

In addition to its role in kinase inhibition, Methyl Piperidine-3-carboxylate Hydrochloride has been investigated for its applications in central nervous system (CNS) drug development. The piperidine ring's ability to penetrate the blood-brain barrier makes it an attractive scaffold for neuroactive compounds. Preliminary studies suggest that derivatives of this compound may exhibit potential in treating neurological disorders such as Alzheimer's and Parkinson's disease. The hydrochloride salt form enhances the compound's stability and solubility, facilitating its use in formulation development.

The synthesis of Methyl Piperidine-3-carboxylate Hydrochloride involves multi-step organic reactions, typically starting from readily available precursors like piperidine. Advanced synthetic methodologies, including catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to achieve high yields and purity. These synthetic strategies not only optimize production efficiency but also minimize environmental impact, aligning with green chemistry principles.

The chemical properties of Methyl Piperidine-3-carboxylate Hydrochloride make it a versatile intermediate for various pharmaceutical applications. Its reactivity allows for further functionalization, enabling the creation of diverse molecular structures with tailored biological activities. This flexibility is particularly valuable in medicinal chemistry, where structural modifications can significantly influence drug potency and selectivity.

Industrial-scale production of Methyl Piperidine-3-carboxylate Hydrochloride requires stringent quality control measures to ensure consistency and compliance with regulatory standards. Analytical techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy are employed to verify the compound's purity and structural integrity. These rigorous quality assurance protocols are essential for maintaining the reliability of pharmaceutical intermediates used in drug development.

The future prospects of Methyl Piperidine-3-carboxylate Hydrochloride are promising, with ongoing research exploring its potential in emerging therapeutic areas. Innovations in computational chemistry and artificial intelligence are accelerating the discovery of novel drug candidates derived from this compound. By leveraging these advanced technologies, scientists can predict molecular interactions and optimize drug design more efficiently than ever before.

In conclusion, Methyl Piperidine-3-carboxylate Hydrochloride (CAS No. 89895-55-6) is a pivotal compound in pharmaceutical chemistry, with significant implications for drug development across multiple therapeutic domains. Its unique structural features and reactivity make it an indispensable intermediate for synthesizing bioactive molecules. As research continues to uncover new applications for this compound, its importance in advancing medicinal chemistry is undeniable.

• 164323-84-6(methyl (3S)-piperidine-3-carboxylate hydrochloride)
• 191544-70-4(3,5-Piperidinedicarboxylic acid, monomethyl ester, hydrochloride)
• 1439815-15-2(Methyl 5-methylpiperidine-3-carboxylate hydrochloride)
• 1211510-61-0(Dimethyl 3,5-piperidinedicarboxylate hydrochloride)
• 1009376-67-3(methyl cis-4-methylpiperidine-3-carboxylate;hydrochloride)
• 114704-14-2(3,4-Piperidinedicarboxylic acid, 3-methyl ester, hydrochloride, cis-)
• 1255651-12-7(methyl (3R)-piperidine-3-carboxylate hydrochloride)
• 164323-85-7(methyl (3R)-piperidine-3-carboxylate)
• 1205749-28-5(methyl 3-ethyl-3-piperidinecarboxylate hydrochloride)
• 1205749-70-7(Methyl 3-methylpiperidine-3-carboxylate hydrochloride)